# A Dose-response Study of Dietary Resveratrol on Lipid Metabolism Disorder

> **NCT04886297** · PHASE3 · COMPLETED · sponsor: **Sun Yat-sen University** · enrollment: 168 (actual)

## Conditions studied

- Dyslipidemias

## Interventions

- **DRUG:** Mega Resveratrol® capsules
- **DRUG:** Mega Resveratrol® Placebo capsules

## Key facts

- **NCT ID:** NCT04886297
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-05-01
- **Primary completion:** 2022-05-30
- **Final completion:** 2022-09-30
- **Target enrollment:** 168 (ACTUAL)
- **Last updated:** 2022-10-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04886297

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04886297, "A Dose-response Study of Dietary Resveratrol on Lipid Metabolism Disorder". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04886297. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*